NowRx 2021 Momentum – in Revenue, Expanded Services and Service Areas, Equity Raises, and More – Makes it a Healthcare Company to Watch in 2022

NowRx 2021 Momentum – in Revenue, Expanded Services and Service Areas, Equity Raises, and More – Makes it a Healthcare Company to Watch in 2022

Company is capitalizing on key trends thanks to its newest telehealth product, proprietary “QuickFill” software, use of intelligent automation…

ResBiotic Spins Out Pharmaceutical Subsidiary Alveolus Bio, Raises $4.5M Seed Funding and Launches First Consumer Health Product

ResBiotic Spins Out Pharmaceutical Subsidiary Alveolus Bio, Raises $4.5M Seed Funding and Launches First Consumer Health Product

The 1st Science-Backed Probiotic for Lung Health is Here Birmingham, Alabama-based biotech startup ResBiotic announced the spin-out of its drug development…

NowRx Launches $73 Million Series C Round on Equity Crowdfunding Platform SeedInvest; Funds Will be Used to Expand Same Day Delivery of Prescriptions and Telehealth Services

NowRx Launches $73 Million Series C Round on Equity Crowdfunding Platform SeedInvest; Funds Will be Used to Expand Same Day Delivery of Prescriptions and Telehealth Services

Digital health platform’s last equity fundraising round was oversubscribed and raised $20 Million; NowRx has since expanded into additional…

Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences to Secure and Support U.S.-Based Drug Supply and Manufacturing

Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences to Secure and Support U.S.-Based Drug Supply and Manufacturing

Drug shortages have long plagued U.S. healthcare providers; COVID-19 has compounded sourcing challenges. New initiative will manufacture pharmaceutical products…